Does Adolescent Idıopathic Scoliosis Cause Pelvic Floor Dysfunction?

Sponsor
Cyprus International University (Other)
Overall Status
Completed
CT.gov ID
NCT06063447
Collaborator
Near East University, Turkey (Other)
12
1
4.5
2.7

Study Details

Study Description

Brief Summary

The aim of this study was to investigate relationship between the type and severity of scoliosis and pelvic floor dysfunctions in individuals with adolescent idiopathic scoliosis.

Condition or Disease Intervention/Treatment Phase
  • Other: Examination

Detailed Description

While a healthy spine has a flat appearance in the axial line in the frontal plane, individuals with scoliosis have lateral flexion to one side and rotation deformity in the horizantal plane. In other words, it is a 3-dimensional problem that causes severe postural disorder in advanced stages, accompanied by lateral flexion of the spine of 10 degrees or more in the frontal plane, axial rotation in the transverse plane and kyphosis-lordosis deformity in the sagittal plane. Especially the "core" region, which is formed by 4 main muscle groups, stabilizes the pelvic organs by balancing intra-abdominal pressure increases and provides spinal stabilization. Studies showing that pelvic floor functions may be affected in normal spinal physiologic curvature changes are available in the literature. However, the relationship between the angle and severity of scoliosis and pelvic floor dysfunctions due to idiopathic scoliosis has not been clearly clarified.

In this context, the study aims to evaluate and compare scoliosis-related parameters (type of scoliosis, cobb angle, axial rotation angle), pelvic floor dynamics and dysfunctions in individuals with idiopathic scoliosis and healthy individuals with the same age group and characteristics.

Study Design

Study Type:
Observational [Patient Registry]
Actual Enrollment :
12 participants
Observational Model:
Other
Time Perspective:
Cross-Sectional
Official Title:
Relationship Between the Type and Severity of Scoliosis and Pelvic Floor Dysfunctions in Individiuals With Adolescent Idiopathic Scoliosis
Actual Study Start Date :
May 2, 2023
Actual Primary Completion Date :
Sep 4, 2023
Actual Study Completion Date :
Sep 15, 2023

Outcome Measures

Primary Outcome Measures

  1. Scoliosis [10 minutes]

    With X-Ray

  2. Posture Analysis [5 minutes]

    With Posture Screen Mobile Application

  3. Pelvic Floor Muscle Activity [15 Minutes]

    With Real Time Transabdominal Ultrasound

  4. Pelvic Floor Dysfunction [5 minutes]

    With Pelvic Floor Distress Inventory

  5. Dysfunctional Voiding [10 minutes]

    With Dysfunctional Voiding Scoring System

Eligibility Criteria

Criteria

Ages Eligible for Study:
11 Years to 18 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  • Those with adolescent idiopathic scoliosis diagnosed above 10' degree,

  • Under 19 years of age diagnosed with AIS,

  • Individuals whose consent was obtained from their families to participate in the study

Exclusion Criteria:
  • Those with congenital scoliosis,

  • Those with a history of neuromuscular disease,

  • Diagnosed with any systemic disease other than AIS,

  • Those with a history of malignancy and/or ongoing treatment,

  • Those with a history of urogenital diseases and surgical history,

  • Individuals with previous spinal surgery

Contacts and Locations

Locations

Site City State Country Postal Code
1 Batuhan Ibrahim Mersin Lefkosa Turkey 99258

Sponsors and Collaborators

  • Cyprus International University
  • Near East University, Turkey

Investigators

  • Study Chair: Salih Angın, Prof., Cyprus International University

Study Documents (Full-Text)

None provided.

More Information

Publications

Responsible Party:
Cyprus International University
ClinicalTrials.gov Identifier:
NCT06063447
Other Study ID Numbers:
  • 020-6029
First Posted:
Oct 2, 2023
Last Update Posted:
Oct 2, 2023
Last Verified:
Sep 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Oct 2, 2023